<PAGE>
===============================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT: FEBRUARY 15, 2000
DATE OF EARLIEST EVENT REPORTED: N.A.
UNITED MEDICORP, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
COMMISSION FILE NUMBER 1-10418
DELAWARE 75-2217002
(STATE OR OTHER JURISDICTION OF (I.R.S. EMPLOYER
INCORPORATION OR ORGANIZATION) IDENTIFICATION NO.)
10210 NORTH CENTRAL EXPRESSWAY
SUITE 400
DALLAS, TEXAS 75231
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (214) 691-2140
N.A.
-------------------------------------------------------------
(FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT)
===============================================================================
<PAGE>
UNITED MEDICORP, INC. AND SUBSIDIARIES
ITEM 5. OTHER EVENTS
On February 11, 2000, the Board of Directors granted common stock purchase
warrants ("Warrants") to two officers as consideration for their personal
guarantees of the Company's recently announced recourse factoring agreement.
Warrants for 2,000,000 shares of the Company's common stock were granted to
both Peter W. Seaman, Chairman and CEO, and Ken Culver, Vice President and
CFO, as consideration for their personal guarantees of the factoring
agreement executed by the Company on December 28, 1999. The Warrants were
exerciseable to the extent of not more than 500,000 shares each on the grant
date and are exerciseable to the extent of not more than 1,500,000 shares
each when the Company becomes eligible for bank financing. The Warrants carry
an exercise price of $0.00 per share and a term of ten years.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
UNITED MEDICORP, INC.
(REGISTRANT)
By: /s/ R. Kenyon Culver Date: February 15, 2000
------------------------------------------ ------------------
R. Kenyon Culver
Vice President and Chief Financial Officer
(Principal Accounting Officer)
1
